眼科用ドラッグデリバリーシステム市場規模、シェア、動向分析レポート：技術別、デリバリールート別、生産技術別、材料別、地域別、セグメント別予測、2025年～2030年

眼科用ドラッグデリバリーシステム市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の眼科用ドラッグデリバリーシステム市場規模は2030年までに233億6,000万米ドルに達すると予測されています。

同市場は2025～2030年にかけてCAGR 6.6%で拡大すると予測されています。眼科疾患の有病率の増加、処置後のきめ細かなケアを必要とする眼科処置の増加、小児と高齢者向けに制御された剤形を提供する必要性の増加などの要因が、市場の成長を促進すると予測されています。加えて、技術的進歩への絶え間ない注力が、市場の著しい成長をさらに後押ししています。例えば、メーカーがナノ技術に即座に注力することで、エラーのないドラッグデリバリーが実現し、標的部位への薬剤の浸透レベルが高まっています。

COVID-19パンデミックの前半には、眼科用ドラッグデリバリーシステムの売上が急減しました。各国での封鎖や政府による様々な規制により、病院やクリニックへの患者の来院数が減少しました。さらに、サプライチェーンの混乱は、市場全体への悪影響を示すこれらの製品の不足にもつながりました。しかし、集団予防接種プログラムや研究開発活動への多額の投資を通じて、ウイルスの蔓延を抑制し、ウイルスがもたらす悪影響を抑えるための政府の取り組みにより、予測期間中に市場は回復すると予想されます。

眼科用ドラッグデリバリーシステム市場のレポートハイライト

• 点眼薬セグメントは2024年に最も高い収益シェアを占め、市場を独占しました。点眼薬は最も便利で患者に適合した技術であるため、疾患の影響を抑制するために、ほとんどの眼科処置において治療の第一選択薬として推奨されることが多いからです。
• 眼内セグメントは、滅菌、低刺激性、点眼剤配合の容易さ、涙液に溶けない薬剤の眼内バイオアベイラビリティの向上などの利点があるため、2024年に最も高い売上シェアを占めました。
• 生産技術別では、製剤化技術によって生産される局所点眼薬の採用増加により、製剤化セグメントが2024年に最も高い市場シェアを占めました。
• 材料別では、ハイドロゲルセグメントが2024年に最も高い市場シェアを占めました。
• 北米は、眼科疾患の罹患率の増加、熟練した専門家の存在、政府機関による失明予防のための様々な取り組みにより、2024年に最も高い市場シェアを占めました。
• COVID-19パンデミックは市場にマイナスの影響を与えています。医療の優先順位の変化、社会的距離、世界の封鎖により、病院やクリニックへの患者の訪問が減少しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 眼科用ドラッグデリバリーシステム市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/補助的な市場展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 眼科用ドラッグデリバリーシステム市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19の影響分析

第4章 眼科用ドラッグデリバリーシステム市場：技術別、推定・動向分析

• セグメントダッシュボード
• 世界の眼科用ドラッグデリバリーシステム市場の技術変動分析
• 世界の眼科用ドラッグデリバリーシステム市場規模と動向分析、技術別、2018～2030年
• 点眼薬
• コンタクトレンズ
• 涙点プラグ
• 上強膜インプラント
• 硝子体内インプラント
• 注入微粒子システム
• イオントフォレシス
• マイクロエレクトロ機械式
• ナノキャリア
• ナノ微粒子
• マイクロニードル
• ハイドロゲル
• その他

第5章 眼科用ドラッグデリバリーシステム市場：デリバリールート別、推定・動向分析

• セグメントダッシュボード
• 世界の眼科用ドラッグデリバリーシステム市場のデリバリールート変動分析
• 世界の眼科用ドラッグデリバリーシステム市場規模と動向分析、デリバリールート別、2018～2030年
• エレクトロスピニング
• 3Dプリンティング
• 押出成形
• 配合
• マイクロパターニング
• 圧縮成形
• その他

第6章 眼科用ドラッグデリバリーシステム市場：生産技術別、推定・動向分析

• セグメントダッシュボード
• 世界の眼科用ドラッグデリバリーシステム市場の生産技術変動分析
• 世界の眼科用ドラッグデリバリーシステム市場規模と動向分析、生産技術別、2018～2030年
• リポソーム
• コラーゲン
• PLA-PEG
• PDO/PVA
• ハイドロゲル
• ティーエムシー
• ポリオルトエステル
• PLGA
• 脂肪酸
• その他

第7章 眼科用ドラッグデリバリーシステム市場：材料別、推定・動向分析

• セグメントダッシュボード
• 世界の眼科用ドラッグデリバリーシステム市場の材料変動分析
• 世界の眼科用ドラッグデリバリーシステム市場規模と動向分析、材料別、2018～2030年
• リポソーム
• コラーゲン
• PLA-PEG
• PDO/PVA
• ハイドロゲル
• ティーエムシー
• ポリオルトエステル
• PLGA
• 脂肪酸
• その他

第8章 眼科用ドラッグデリバリーシステム市場：地域別、推定・動向分析

• 地域別市場シェア分析、2023年と2030年
• 地域別市場ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 企業/競合の分類
• 戦略マッピング
• 企業市況分析、2023年
• 主要な認証プロバイダー/スキーム所有者一覧
• 企業プロファイル/上場企業
  • Ocular Therapeutix Inc.
  • Allergan plc.
  • Santen Pharmaceutical Co. Ltd.
  • Envisia Therapeutics
  • pSivida
  • Clearside Biomedical
  • Oculis Pharma
  • Valeant Pharmaceuticals
  • AptarGroup, Inc.
  • 企業概要

List of Tables

• Table 1 List of abbreviation
• Table 2 Global ophthalmic drug delivery systems market, by region, 2018 - 2030 (USD Billion)
• Table 3 Global ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 4 Global ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 5 Global ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 6 Global ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 7 North America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
• Table 8 North America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 9 North America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 10 North America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 11 North America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 12 U.S. ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 13 U.S. ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 14 U.S. ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 15 U.S. ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 16 Canada ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 17 Canada ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 18 Canada ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 19 Canada ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 20 Mexico ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 21 Mexico ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 22 Mexico ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 23 Mexico ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 24 Europe ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
• Table 25 Europe ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 26 Europe ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 27 Europe ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 28 Europe ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 29 UK ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 30 UK ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 31 UK ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 32 UK ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 33 Germany ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 34 Germany ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 35 Germany ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 36 Germany ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 37 France ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 38 France ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 39 France ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 40 France ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 41 Italy ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 42 Italy ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 43 Italy ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 44 Italy ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 45 Spain ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 46 Spain ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 47 Spain ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 48 Spain ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 49 Denmark ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 50 Denmark ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 51 Denmark ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 52 Denmark ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 53 Sweden ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 54 Sweden ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 55 Sweden ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 56 Sweden ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 57 Norway ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 58 Norway ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 59 Norway ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 60 Norway ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 61 Asia Pacific ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
• Table 62 Asia Pacific ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 63 Asia Pacific ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 64 Asia Pacific ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 65 Asia Pacific ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 66 Japan ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 67 Japan ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 68 Japan ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 69 Japan ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 70 China ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 71 China ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 72 China ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 73 China ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 74 India ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 75 India ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 76 India ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 77 India ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 78 Australia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 79 Australia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 80 Australia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 81 Australia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 82 South Korea ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 83 South Korea ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 84 South Korea ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 85 South Korea ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 86 Thailand ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 87 Thailand ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 88 Thailand ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 89 Thailand ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 90 Latin America ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
• Table 91 Latin America ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 92 Latin America ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 93 Latin America ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 94 Latin America ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 95 Brazil ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 96 Brazil ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 97 Brazil ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 98 Brazil ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 99 Argentina ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 100 Argentina ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 101 Argentina ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 102 Argentina ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 103 MEA ophthalmic drug delivery systems market, by country, 2018 - 2030 (USD Billion)
• Table 104 MEA ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 105 MEA ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 106 MEA ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 107 MEA ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 108 South Africa ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 109 South Africa ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 110 South Africa ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 111 South Africa ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 112 Saudi Arabia ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 113 Saudi Arabia ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 114 Saudi Arabia ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 115 Saudi Arabia ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 116 UAE ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 117 UAE ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 118 UAE ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 119 UAE ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)
• Table 120 Kuwait ophthalmic drug delivery systems market, by technology, 2018 - 2030 (USD Billion)
• Table 121 Kuwait ophthalmic drug delivery systems market, by delivery route, 2018 - 2030 (USD Billion)
• Table 122 Kuwait ophthalmic drug delivery systems market, by production technology, 2018 - 2030 (USD Billion)
• Table 123 Kuwait ophthalmic drug delivery systems market, by material, 2018 - 2030 (USD Billion)

List of Figures

• Fig. 1 Ophthalmic drug delivery systems market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 Ophthalmic drug delivery systems market: Technology outlook key takeaways
• Fig. 20 Ophthalmic drug delivery systems market: Technology movement analysis
• Fig. 21 Eye drops market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 22 Contact lenses market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 23 Punctal plugs market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 24 Episcleral implants market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 25 Intravitreal implants market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 26 Injectable particulate systems market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 27 Iontophoresis market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 28 Micro-Electromechanical market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 29 Nano careers market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 30 Nano microparticles market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 31 Microneedles market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 32 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 34 Ophthalmic drug delivery systems market: Delivery route outlook key takeaways
• Fig. 35 Ophthalmic drug delivery systems market: Delivery route movement analysis
• Fig. 36 Intraocular market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 37 Intravitreal market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 38 Intracameral market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 39 Ophthalmic drug delivery systems market: Production technology outlook key takeaways
• Fig. 40 Ophthalmic drug delivery systems market: Production technology movement analysis
• Fig. 41 Electrospinning market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 42 3D printing market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 43 Formulation market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 44 Micro patterning market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 45 Compression molding market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 47 Ophthalmic drug delivery systems market: Material outlook key takeaways
• Fig. 48 Ophthalmic drug delivery systems market: Material movement analysis
• Fig. 49 Liposomes market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 50 Collagen market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 51 PLA-PEG market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 52 PDO/PVA market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 53 Hydrogels market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 54 TMC market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 55 Polyorthoesters market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 56 PLGA market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 57 Polycaprolactone market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 58 Fatty acids market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 59 Others market estimates and forecast, 2018 - 2030 (USD Billion)
• Fig. 60 Regional marketplace outlook, 2024 & 2030 (USD Billion)
• Fig. 61 Regional marketplace: Key takeaways
• Fig. 62 North America ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 63 Key country dynamics
• Fig. 64 U.S. ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 65 Key country dynamics
• Fig. 66 Canada ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 67 Key country dynamics
• Fig. 68 Mexico ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 69 Europe ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 70 Key country dynamics
• Fig. 71 UK ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 72 Key country dynamics
• Fig. 73 Germany ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 74 Key country dynamics
• Fig. 75 France ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 76 Key country dynamics
• Fig. 77 Spain ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 78 Key country dynamics
• Fig. 79 Italy ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 80 Key country dynamics
• Fig. 81 Denmark ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 82 Key country dynamics
• Fig. 83 Sweden ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 84 Key country dynamics
• Fig. 85 Norway ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 86 Asia Pacific ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 87 Key country dynamics
• Fig. 88 Japan ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 89 Key country dynamics
• Fig. 90 China ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 91 Key country dynamics
• Fig. 92 India ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 93 Key country dynamics
• Fig. 94 Australia ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 95 Key country dynamics
• Fig. 96 South Korea ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 97 Key country dynamics
• Fig. 98 Thailand ophthalmic drug delivery systems market estimates and forecasts, 2018 - 2030 (USD Billion)
• Fig. 99 Key country dynamics
• Fig. 100 Market participant categorization
• Fig. 101 Ophthalmic drug delivery systems market position analysis, 2023
• Fig. 102 Strategic framework

Ophthalmic Drug Delivery Systems Market Growth & Trends:

The global ophthalmic drug delivery systems market size is projected to reach USD 23.36 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.6% from 2025 to 2030. Factors such as growing prevalence of ophthalmic diseases, rise in number of ophthalmic procedures that require attentive post procedural care and increase in need to deliver controlled dosage forms for pediatric and geriatric population are anticipated to propel the growth of the market. In addition, immense focus on technological advancements is further helping the market to grow at a significant rate. For instance, manufacturers' instant focus on nanotechnology has helped to deliver error-free drug delivery and increase the penetration level of the drug at the target site.

The market observed a sudden fall in sales of ophthalmic drug delivery systems during the first half of the COVID-19 pandemic. The lockdowns across different countries and various restrictions led down by the government led to fall in number of patient's visits to the hospitals and clinics. Moreover, the disruption in supply chains also led to a shortage of these products which indicates an overall negative impact on the market. However, with the government's initiatives to curb the spread of the virus and limit the negative consequences it possesses via mass vaccination programs and heavy investment in R&D activities, the market is expected to recover over the forecast period.

Ophthalmic Drug Delivery Systems Market Report Highlights:

• The eye drops segment dominated the market with highest revenue share in 2024 as eye drops are often recommended as the first line of treatment in most of the ophthalmic procedures to control the effect of the disease as it is the most convenient and patient compliant technology.
• The intraocular segment held the highest revenue share in 2024 owing to the advantages it offers such as sterilization, less irritation, ease of eye drops formulation and enhancement in ocular bioavailability of drugs that are insoluble in tear fluid.
• On the basis of production technology, the formulation segment accounted for highest market share in 2024 owing to increase in adoption of topical eye drops which is produced through the formulation technology.
• Based on material, the hydrogels segment held the highest market share in 2024 owing to the advantages it offers over other materials.
• North America accounted for highest market share in 2024 due to increasing incidence of ophthalmic disorders, presence of skilled professionals and various initiatives undertaken by the government agencies to prevent blindness in the region.
• The COVID-19 pandemic has a negative impact on the market. Due to change in healthcare priorities, social distancing, worldwide lockdowns led to reduced patient visits to the hospitals and clinics.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Technology Segment
  • 1.2.2. Delivery Route Segment
  • 1.2.3. Production Technology Segment
  • 1.2.4. Material Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Segment Snapshot
• 2.4. Competitive Insights Landscape

Chapter 3. Ophthalmic Drug Delivery Systems Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Ophthalmic Drug Delivery Systems Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Ophthalmic Drug Delivery Systems Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Ophthalmic Drug Delivery Systems Market Technology Movement Analysis
• 4.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Technology, 2018 - 2030 (USD Billion)
• 4.4. Eye Drops
  • 4.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.5. Contact Lenses
  • 4.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.6. Punctal Plugs
  • 4.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.7. Episcleral Implants
  • 4.7.1.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.8. Intraviteal Implants
  • 4.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.9. Injectable Particulate Systems
  • 4.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.10. Iontophoresis
  • 4.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.11. Micro-Electromechanical
  • 4.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.12. Nano careers
  • 4.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.13. Nano microparticles
  • 4.13.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.14. Microneedles
  • 4.14.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.15. Hydrogels
  • 4.15.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 4.16. Others
  • 4.16.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 5. Ophthalmic Drug Delivery Systems Market: Delivery Route Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Ophthalmic Drug Delivery Systems Market Delivery Route Movement Analysis
• 5.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Delivery Route, 2018 - 2030 (USD Billion)
• 5.4. Electrospinning
  • 5.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.5. 3D Printing
  • 5.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.6. Extrusion
  • 5.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.7. Formulation
  • 5.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.8. Micropatterning
  • 5.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.9. Compression molding
  • 5.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 5.10. Others
  • 5.10.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 6. Ophthalmic Drug Delivery Systems Market: Production Technology Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Ophthalmic Drug Delivery Systems Market Production Technology Movement Analysis
• 6.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Production Technology, 2018 - 2030 (USD Billion)
• 6.4. Liposomes
  • 6.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.5. Collagen
  • 6.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.6. PLA-PEG
  • 6.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.7. PDO/PVA
  • 6.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.8. Hydrogels
  • 6.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.9. TMC
  • 6.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.10. Polyorthoesters
  • 6.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.11. PLGA
  • 6.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.12. Fatty acids
  • 6.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 6.13. Others
  • 6.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 7. Ophthalmic Drug Delivery Systems Market: Material Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Ophthalmic Drug Delivery Systems Market Material Movement Analysis
• 7.3. Global Ophthalmic Drug Delivery Systems Market Size & Trend Analysis, by Material, 2018 - 2030 (USD Billion)
• 7.4. Liposomes
  • 7.4.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.5. Collagen
  • 7.5.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.6. PLA-PEG
  • 7.6.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.7. PDO/PVA
  • 7.7.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.8. Hydrogels
  • 7.8.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.9. TMC
  • 7.9.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.10. Polyorthoesters
  • 7.10.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.11. PLGA
  • 7.11.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.12. Fatty acids
  • 7.12.1. Market estimates and forecast 2018 - 2030 (USD Million)
• 7.13. Others
  • 7.13.1. Market estimates and forecast 2018 - 2030 (USD Million)

Chapter 8. Ophthalmic Drug Delivery Systems Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2023 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Market Size, & Forecasts Trend Analysis, 2018 - 2030:
• 8.4. North America
  • 8.4.1. U.S.
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Competitive scenario
    • 8.4.1.3. Regulatory framework
    • 8.4.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.4.2. Canada
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Competitive scenario
    • 8.4.2.3. Regulatory framework
    • 8.4.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.4.3. Mexico
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Competitive scenario
    • 8.4.3.3. Regulatory framework
    • 8.4.3.4. Mexico market estimates and forecasts 2018 - 2030 (USD Billion)
• 8.5. Europe
  • 8.5.1. UK
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Competitive scenario
    • 8.5.1.3. Regulatory framework
    • 8.5.1.4. UK market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.2. Germany
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Competitive scenario
    • 8.5.2.3. Regulatory framework
    • 8.5.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.3. France
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Competitive scenario
    • 8.5.3.3. Regulatory framework
    • 8.5.3.4. France market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.4. Italy
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Competitive scenario
    • 8.5.4.3. Regulatory framework
    • 8.5.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.5. Spain
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Competitive scenario
    • 8.5.5.3. Regulatory framework
    • 8.5.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.6. Denmark
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Competitive scenario
    • 8.5.6.3. Denmark market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.7. Sweden
    • 8.5.7.1. Key country dynamics
    • 8.5.7.2. Competitive scenario
    • 8.5.7.3. Regulatory framework
    • 8.5.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.5.8. Norway
    • 8.5.8.1. Key country dynamics
    • 8.5.8.2. Competitive scenario
    • 8.5.8.3. Regulatory framework
    • 8.5.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Billion)
• 8.6. Asia Pacific
  • 8.6.1. Japan
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Competitive scenario
    • 8.6.1.3. Regulatory framework
    • 8.6.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6.2. China
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Competitive scenario
    • 8.6.2.3. Regulatory framework
    • 8.6.2.4. China market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6.3. India
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Competitive scenario
    • 8.6.3.3. Regulatory framework
    • 8.6.3.4. India market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6.4. Australia
    • 8.6.4.1. Key country dynamics
    • 8.6.4.2. Competitive scenario
    • 8.6.4.3. Regulatory framework
    • 8.6.4.4. Australia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6.5. South Korea
    • 8.6.5.1. Key country dynamics
    • 8.6.5.2. Competitive scenario
    • 8.6.5.3. Regulatory framework
    • 8.6.5.4. South Korea market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.6.6. Thailand
    • 8.6.6.1. Key country dynamics
    • 8.6.6.2. Competitive scenario
    • 8.6.6.3. Regulatory framework
    • 8.6.6.4. Thailand market estimates and forecasts 2018 - 2030 (USD Billion)
• 8.7. Latin America
  • 8.7.1. Brazil
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Competitive scenario
    • 8.7.1.3. Regulatory framework
    • 8.7.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.7.2. Argentina
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Competitive scenario
    • 8.7.2.3. Regulatory framework
    • 8.7.2.4. Argentina market estimates and forecasts 2018 - 2030 (USD Billion)
• 8.8. MEA
  • 8.8.1. South Africa
    • 8.8.1.1. Key country dynamics
    • 8.8.1.2. Competitive scenario
    • 8.8.1.3. Regulatory framework
    • 8.8.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.8.2. Saudi Arabia
    • 8.8.2.1. Key country dynamics
    • 8.8.2.2. Competitive scenario
    • 8.8.2.3. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.8.3. UAE
    • 8.8.3.1. Key country dynamics
    • 8.8.3.2. Competitive scenario
    • 8.8.3.3. Regulatory framework
    • 8.8.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Billion)
  • 8.8.4. Kuwait
    • 8.8.4.1. Key country dynamics
    • 8.8.4.2. Competitive scenario
    • 8.8.4.3. Regulatory framework
    • 8.8.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

• 9.1. Company/Competition Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2023
• 9.4. List of Key Certification Providers/Scheme Owners
• 9.5. Company Profiles/Listing
  • 9.5.1. Ocular Therapeutix Inc.
    • 9.5.1.1. Company overview
    • 9.5.1.2. Financial performance
    • 9.5.1.3. Technology benchmarking
    • 9.5.1.4. Strategic initiatives
  • 9.5.2. Allergan plc.
    • 9.5.2.1. Company overview
    • 9.5.2.2. Financial performance
    • 9.5.2.3. Technology benchmarking
    • 9.5.2.4. Strategic initiatives
  • 9.5.3. Santen Pharmaceutical Co. Ltd.
    • 9.5.3.1. Company overview
    • 9.5.3.2. Financial performance
    • 9.5.3.3. Technology benchmarking
    • 9.5.3.4. Strategic initiatives
  • 9.5.4. Envisia Therapeutics
    • 9.5.4.1. Company overview
    • 9.5.4.2. Financial performance
    • 9.5.4.3. Technology benchmarking
    • 9.5.4.4. Strategic initiatives
  • 9.5.5. pSivida
    • 9.5.5.1. Company overview
    • 9.5.5.2. Financial performance
    • 9.5.5.3. Technology benchmarking
    • 9.5.5.4. Strategic initiatives
  • 9.5.6. Clearside Biomedical
    • 9.5.6.1. Company overview
    • 9.5.6.2. Financial performance
    • 9.5.6.3. Technology benchmarking
    • 9.5.6.4. Strategic initiatives
  • 9.5.7. Oculis Pharma
    • 9.5.7.1. Company overview
    • 9.5.7.2. Financial performance
    • 9.5.7.3. Technology benchmarking
    • 9.5.7.4. Strategic initiatives
  • 9.5.8. Valeant Pharmaceuticals
    • 9.5.8.1. Company overview
    • 9.5.8.2. Financial performance
    • 9.5.8.3. Technology benchmarking
    • 9.5.8.4. Strategic initiatives
  • 9.5.9. AptarGroup, Inc.
  • 9.5.9. Company overview
    • 9.5.9.1. Financial performance
    • 9.5.9.2. Technology benchmarking
    • 9.5.9.3. Strategic initiatives